NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

BioCardia Inc (NASDAQ: BCDAW)

 
BCDAW Technical Analysis
3
As on 6th Dec 2021 BCDAW Share Price closed @ 1.05 and we RECOMMEND Sell for LONG-TERM with Stoploss of 1.19 & Sell for SHORT-TERM with Stoploss of 1.36 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

BCDAW Share Price

Open 1.05 Change Price %
High 1.05 1 Day 0.00 0.00
Low 1.05 1 Week -0.15 -12.50
Close 1.05 1 Month -0.82 -43.85
Volume 10 1 Year 0.43 69.35
52 Week High 2.45 | 52 Week Low 0.52
 
NASDAQ USA Most Active Stocks
AAPL 165.32 2.15%
LCID 44.86 -5.10%
SNDL 0.57 1.79%
ISIG 15.05 204.66%
CFVI 12.70 6.72%
AAL 17.93 7.88%
ARDX 1.38 -9.21%
AMD 139.06 -3.44%
NVDA 300.37 -2.14%
ACET 13.57 38.47%
 
NASDAQ USA Top Gainers Stocks
TPGY-WT 10.16 636.23%
ISIG 15.05 204.66%
NVNOW 0.33 73.68%
TACO 12.51 66.14%
CPIX 6.94 51.20%
ACET 13.57 38.47%
VYNE 1.20 31.87%
BOWXW 2.97 29.13%
EFTR 7.37 29.07%
OXBRW 0.50 28.21%
 
NASDAQ USA Top Losers Stocks
HEC 0.00 -100.00%
HEC 0.00 -100.00%
HEC 0.00 -100.00%
ADMS 0.00 -100.00%
THMA 0.49 -94.73%
PTRAW 0.23 -89.59%
SGOC 4.95 -55.84%
BOLT 4.64 -55.81%
BOLT 4.64 -55.81%
BOLT 4.64 -55.81%
 
 
BCDAW
Daily Charts
BCDAW
Intraday Charts
Whats New @
Bazaartrend
BCDAW
Free Analysis
 
BCDAW Important Levels Intraday
RESISTANCE1.05
RESISTANCE1.05
RESISTANCE1.05
RESISTANCE1.05
RESISTANCE1.05
RESISTANCE1.05
RESISTANCE1.05
RESISTANCE1.05
 
BCDAW Target for Month December
4th UP TARGET6.79
3rd UP TARGET4.95
2nd UP TARGET3.81
1st UP TARGET2.67
1st DOWN TARGET-0.57
2nd DOWN TARGET-1.71
3rd DOWN TARGET-2.85
4th DOWN TARGET-4.69
 
BCDAW Weekly Target
4th UP TARGET1.59
3rd UP TARGET1.42
2nd UP TARGET1.31
1st UP TARGET1.20
1st DOWN TARGET0.90
2nd DOWN TARGET0.79
3rd DOWN TARGET0.68
4th DOWN TARGET0.51
 
BCDAW Target for Year 2021
4th UP TARGET6.79
3rd UP TARGET4.95
2nd UP TARGET3.81
1st UP TARGET2.67
1st DOWN TARGET-0.57
2nd DOWN TARGET-1.71
3rd DOWN TARGET-2.85
4th DOWN TARGET-4.69
 
 
BCDAW Other Details
Segment EQ
Market Capital 0.00
Sector Other
Industry Other
Offical website >
 
BCDAW Address
BCDAW
 
BCDAW Latest News
 
Your Comments and Response on BioCardia Inc
 
BCDAW Business Profile
BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapeutics for cardiovascular diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia. The company is also developing CardiALLO Cell Therapy System, an investigational culture expanded bone marrow derived from mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic systolic heart failure. In addition, it offers the Helix biotherapeutic delivery system; and Morph vascular access product line, which provides catheter products. BioCardia, Inc. is based in San Carlos, California. Address:
 
2005-2021 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service